NCT00528281 2017-11-17
A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase
GlaxoSmithKline
Phase 1 Completed
GlaxoSmithKline
University of California, San Francisco
Georgetown University